Hendrik Heers

4PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|May 25, 2024
Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach.

Hendrik Heers, Josef Maximilian Gut, Rainer Hofmann

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Sep 25, 2023
[Geriatric assessment - What should be done and considered before starting therapy of mHSPC and mCRPC?]

Hendrik Heers, Marius Cristian Butea-Bocu, Christer Groeben

Pageof 1

Frequent Collaborators

2 joint publications

Niklas Klümper

2 joint publications

Katrin Schlack

2 joint publications

Oliver Hahn

2 joint publications

Thomas Büttner